A positive chronic hepatitis B diagnosis requires follow-up, from clinical tests to patient education, including:
A thorough history and physical examination followed by evaluation tests
Patient education regarding modes of transmission, the potential course of their disease, and their current status and next steps in its management, which may help empower them to participate in their disease management
1. Shah HA, Abu-Amara M. Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review. Clin Gastroenterol Hepatol. 2013;11:922-933.
2. Martin P, Lau D, Nguyen M, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update. Clin Gastroenterol Hepatol. 2015;13:2071-2087.
3. Weinbaum CM, Williams I, Mast EE, et al., and The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR08):1-20.
4. Centers for Disease Control and Prevention. Hepatitis B. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine - Preventable Diseases. 13th ed. Washington D.C.: Public Health Foundation;2015:149-174.
5. Kim WR. Epidemiology of hepatitis B in the United States. 2009;49(5 suppl):S28–S34.
6. World Health Organization. Hepatitis B fact sheet. www.who.int/mediacentre/factsheets/fs204/en/. Updated July 2017. Accessed August 2017.
7. Asian Liver Center at Stanford University. 2013 Physician’s Guide to Hepatitis B: A silent Killer. Palo Alto, CA: Asian Liver Center; 2014.
8. Sarin SK, Kumar M. Epidemiology, screening, and natural history of chronic hepatitis B infection. In: Shetty K, Wu GY, eds. Clinical Gastroenterology: Chronic Viral Hepatitis. Totowa, NJ: Humana Press; 2009:185-241.
9. Tan NC, Cheah, SL. How do general practitioners improve compliance of disease monitoring by patients with chronic hepatitis B infection in primary care? A qualitative study. Asia Pacific Family Medicine. 2004;3:29-37.
10. Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol. 2012;4:43-49.
11. Fattovich G, Bortolotti F, Donato F, et al. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335-352.
12. Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med. 2014;4:a024935.
13. Terrault N, Bzowej NH, Chang KM, et al. AASLD Guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261-283.
14. Tseng TC, Liu CJ, Yang HC, et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2015;64:292-302.
15. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053-2063.
16. Lin CL, Kap JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;28:10-17.
17. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
18. Tong MJ, Pan CQ, Hann HW, et al. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56:3143-3162.
19. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:1-36.
THIS SITE IS INTENDED FOR US HEALTHCARE PROFESSIONALS ONLY.
HEPBMD, the HEPBMD.COM Logo, HEPBSMART, HEPBSMART.COM, the Liver Icon, GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc. or its related companies. All other trademarks referenced herein are the property of their respective owners.
©2017 Gilead Sciences, Inc. All rights reserved. UNBP3434 8/17